Strategic Medical Department Review

Medical departments within biopharma organisations across the world play a vital role in bridging the gap between scientific research and commercial goals.

Unfortunately, many pharmaceutical organisations struggle to measure or truly appreciate the effectiveness and strategic value of their Medical Affairs teams.

LUCENT was engaged by the UK arm of a global pharma company, hereby referred to as ‘PharmaCo’. PharmaCo’s new General Manager in the UK had a strong commercial background, but lacked the first-hand Medical and Medical Affairs experience needed to align the Medical department with broader business goals.

This is why LUCENT was chosen to deliver a complete Medical department strategic review over the course of eight weeks. To deliver on this, we leveraged our data, analytics, benchmarking and decades of experience working within, and leading, Medical departments.

“The LUCENT team were efficient, professional and highly effective. They delivered insights that we would not have been able to glean by ourselves.”